4.05 Nov 2025Sales representativeCurrent employee, more than 1 yearRecommendCEO approvalBusiness outlookProsPay, sm company stock optionsConsLearning curve start up companyShow more
5.019 Oct 2023Business development specialistFormer employee, less than 1 yearNorth Chicago, ILRecommendCEO approvalBusiness outlookProsWe were off to a great start until the FDA decided that another clinical trial was required before the drug could be launched.ConsLike all start ups, there was a fair amount of chaos.Show moreHelpfulShare
2.015 May 2026Sales representativeCurrent employee, more than 1 yearRecommendCEO approvalBusiness outlookProsAmazing medication and some really great people.ConsC-suite has made bad strategic decisions that are costing the company, and have newly implemented over the top micro management of sales team. Treated like new primary care reps and not specialty reps with 20 years of experience.Show moreHelpfulShare